Delivery Order SPE2DB24D1104-SPE2DB25FYFD9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,725.61 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ml insulin pens on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,003.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ML insulin pens, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $1,199.65 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Novolog Mix 70-30 FlexPen 3mL insulin pens. This firm fixed-price delivery order, with a completion date of July 15, 2025, will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, demonstrating AmerisourceBergen's capability to compete openly for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,851.03 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ml insulin pens on April 24, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of April 25, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is...
- The Defense Logistics Agency awarded a $1,396.34 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3ml insulin pens. This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, valued at $1,862.88. This firm fixed-price delivery order, which concludes on July 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, a widely-used combination insulin product for diabetes management. This firm fixed-price delivery order, valued at $1,252.30, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through...
- The Defense Logistics Agency awarded a $3,834.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded on August 15, 2025, with performance occurring at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a $2,217.78 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3ml insulin pens. This is a firm fixed price, competitively awarded contract with a completion date of July 21, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,562.48 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3mL insulin pens. This is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operations. This...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYFD9Delivery Order
The Defense Logistics Agency awarded a $1,994.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3mL insulin pens, with an ultimate completion date of September 3, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order for diabetes management medication aligns with the contractor's extensive portfolio of pharmaceutical products supplied to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed pricing structure and competitively awarded status reflect AmerisourceBergen's demonstrated capability to meet federal procurement requirements for medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/2/25 |